NRAS and chronic myelomonocytic leukemia: Cargo et al.’s study demonstrates that the presence of certain mutations (ASXL1, CBL, DNMT3A, NRAS, and RUNX1) correlates with similar immunophenotypes and overall survival (OS), regardless of whether the patient was diagnosed with CMML [9].